Non Hodgkin Lymphoma News and Research

RSS

People who have a parent, sibling, or child with blood cancer have higher risk of disease

New data suggest that people who have a parent, sibling, or child with blood cancer have a higher likelihood of being diagnosed with the disease.

9 Aug 2019

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.

25 Jul 2019

CAR-T cells used to target glioblastoma

Immunotherapy is the new weapon against cancers and building upon existing research, a team of researchers from the Massachusetts General Hospital have devised a way to make immunotherapy more effective in a deadly and common form of brain cancer called glioblastoma.

24 Jul 2019

Why it’s so hard to predict how much funding 9/11 first responders need

The idea of getting cancer from searching through the rubble of Ground Zero after the 9/11 attacks — and then standing guard over it for months — didn’t occur to Kevin Zweigbaum.

24 Jul 2019

Researchers develop new compound to block therapeutic target in aggressive blood cancer

Researchers at the UNC Lineberger Comprehensive Cancer Center have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer.

23 Jul 2019

Mathematical model helps quantify metastatic cell behavior

Cancer metastasis is a difficult stage to battle, especially if cancer cells are proliferating at a rapid pace. A new study reveals that metastatic cells change their shape to spread to other parts of the body. Researchers formulated a mathematical model to study metastatic cell behavior and similar cellular systems.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.

24 Jun 2019

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

A new study in JNCI Cancer Spectrum finds that dramatic increases in cancer survival in adolescents and young adults are undermined by continuing disparities by race, ethnicity, and socioeconomic status.

12 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Surgery can be beneficial for one type of primary central nervous system lymphoma

Through a systematic review of published studies going back 50 years, Johns Hopkins Medicine researchers say they have identified a distinct subtype of primary central nervous system lymphoma that should be considered for surgical removal, suggesting a major shift in how this type of tumor is evaluated and managed.

From Johns Hopkins Medicine 29 May 2019

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

The German Institute for Quality and Efficiency in Health Care has investigated whether patients suffering from non-Hodgkin lymphoma have (better) chances of recovery when stem cells from another person are transplanted.

24 May 2019

Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

In the meta-analysis, Luoping Zhang, University of California, Berkeley, and her team pursued the question of whether people who used plant protection products containing glyphosate had an increased risk of contracting Non-Hodgkin Lymphoma, a form of lymph node cancer.

15 Apr 2019

Popular weed killer’s alleged link to cancer spreads concern

Clumps of dandelions have popped up in your yard, so you reach for a bottle of Roundup, the popular weed killer. It is known for being very effective, but its main ingredient, glyphosate, is getting a lot of attention because of lawsuits alleging links to cancer.

4 Apr 2019

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma.

1 Apr 2019

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma

A new study has shown that the herbicide glyphosphate, could increase the risk of Non-Hodgkin Lymphoma by 41 percent among those who are exposed.

15 Feb 2019

Exposure to chemical in weedkiller Roundup raises risk of some cancers, study finds

Exposure to glyphosate--the world's most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup--increases the risk of some cancers by more than 40 percent, according to new research from the University of Washington.

14 Feb 2019

Cancer among Israeli men on the decline says report

According to a report from the Israel Cancer Association yesterday (3rd February 2019), there has been a significant fall in the number of Israeli men getting cancers over that last decade.

3 Feb 2019

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.

24 Dec 2018

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy Yescarta remained in remission more than two years following therapy, and more than half of the patients treated remain alive.

4 Dec 2018